RNA-Extraktion aus Virusproben

Extrahieren Sie hochwertige RNA aus Universal Transport Media (UTM)-Sammelkontainern

  • Basiert auf proprietärer Magnetpartikel-Technologie (SPRI paramagnetic beads)
  • Liefert hochreine virale RNA zur Verwendung in PCR-basierten Anwendungen zur Erforschung von Infektionskrankheiten und Krankheitserregern
  • Automatisierbar, virale Extraktion, die schnell an Liquid-Handling-Plattformen angepasst werden kann
RNAdvance Viral XP ist als Extraktionsmethode zur Verwendung mit dem von der EUA zugelassenen COVID-19-Tests des Centers for Disease Control aufgeführt, auf den in den FAQ der FDA zum Testen auf SARS-CoV-2 verwiesen wird. Abgesehen von dieser Bezeichnung ist RNAdvance Viral XP für Forschungszwecke und nicht für diagnostische Zwecke bestimmt.
RNAdvance Viral reagent kit isolates RNA from Saliva and Swab Transport Media

Performance
Compliance

White Paper
Acquisitions

Customer Spotlight

Protokolle

Customer Interview

Angebot anfordern

SPRI Technologie

Pipettierroboter

RNAdvance Viral Genomic Reagent Kits

Hotline Nummer

Um direkt mit einem Experten in Europa zu sprechen, nutzen Sie unsere spezielle Informationshotline unter +44 (1494) 974000.

RNAdvance Viral Workflow

RNA Isolation from Viral Samples Workflow with RNAdvance Viral XP

Überblick

Übersicht
RNAdvance Viral XP isoliert RNA aus Universal-Transportmedien. RNAdvance Viral isoliert RNA aus Speichel und Tupfertransportmedien.

Hochwertige RNA
Die RNAdvance Viral XP- und RNAdvance Viral-Isolierungskits reinigen intakte RNA auf, die sich für nachfolgende PCR-basierte Anwendungen eignet. Nachweisgrenze (Limit of Detection, LoD) von 1 Kopie/µL für virale RNA.

Flexibel und skalierbar
Die Kombination der RNAdvance-Chemie mit Laborautomation bietet eine Lösung für die Hochdurchsatzverarbeitung mit minimalem Zeitaufwand.

RNAdvance Viral Produktspezifikationen

Application Uses Research Use, RNA Isolation, RNA Extraction, Nucleic Acid Sample Prep, PCR
Format Liquid
Starting Sample Material Saliva and Swab in Universal Transport Media
Automated Available Yes
Item Specifications Referenced C63510

Video zur Produkteinführung: RNAdvance Viral XP Reagent Kit

Title Description
Characterization of the Beckman Coulter's RNAdvance Viral XP RNA Extraction Kit using AccuPlex™ SARS–CoV–2 Reference Material Kit
{E588CF40-730C-4137-A5DC-8DDEAB7CF7D9}
White Paper: iRepertoire performed analytical performance assays and specimen assays to demonstrate that the RNAdvance Viral XP extraction kit has a limit of detection of RNA (LoD) of 1 copy of RNA, specifically tested with AccuPlex™ SARS–CoV–2 Reference Material Kit, per microliter of sample.
Miami Cancer Institute Conducted Virology Research Using RNAdvance Viral
{AF9E1A10-BC29-46AA-A2A1-05BB530B6198}
In this customer spotlight Beckman Coulter Life Sciences had the honor of interviewing Weiming Shen, MS, ASCPCM, Manager of the Genomics Laboratory Service at Miami Cancer Institute, to discuss her team’s progress with virology research.
Viral RNA Extraction Performance using RNAdvance Viral Supplemental Protocol
{442DF88C-CA7F-4B78-AF75-9D2B985534C0}
In this application note we present a research study at Miami Cancer Institute in collaboration with Beckman Coulter Life Sciences using the RNAdvance Viral research reagents described in the Viral Nucleic Acid extraction from swabs using RNAdvance Viral supplemental protocol.
High-throughput qPCR and RT-qPCR Workflows Enabled by Beckman Coulter Echo Acoustic Liquid Handling and NEB® Luna® Reagents
{442DF88C-CA7F-4B78-AF75-9D2B985534C0}
Application Note: We show that NEB Luna qPCR reagents offer strong performance in high-throughput qPCR applications and are readily compatible with automated reaction setup, here using the Beckman Echo 525 acoustic liquid handler.
Viral RNA Extraction from Saliva and Swab Samples
{279C6CA2-9797-4CFE-9CAA-5EAFAC29B60D}
Data Sheet and Performance: SPRI technology enables purification of high-quality RNA with demonstrated compatibility with up to 200 μL of saliva or swab transport media. The protocol can be performed in a single tube or 96-well format with the flexibility to automate on a variety of liquid handling platforms.
The Story Behind Warsaw Genomics’ Automated RNAdvance Viral Extraction Workflow
{AF9E1A10-BC29-46AA-A2A1-05BB530B6198}
In this customer spotlight we interviewed Dr. Monika Kolanowska, Scientist and Laboratory Team Leader at Warsaw Genomics, to discuss the collaboration with Beckman Coulter and how they overcame the challenges associated with the accelerated scale-up.
Viral Inactivation Study of SARS-CoV-2 in Lysis Buffer (LBF)
{611E05FD-FC41-4E23-9498-DA5662F8D4F9}
Technical Note: Review the details and process we uncovered in this inactivation study.